Corium to Report Third Quarter Fiscal 2017 Financial Results on Thursday, August 3, 2017
MENLO PARK, Calif. , July 27, 2017 (GLOBE NEWSWIRE) — Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the third quarter ended June 30, 2017 on Thursday, August 3, 2017 after the close of the U.S. financial markets. Corium will host a conference…

Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex^TM Donepezil Transdermal System at Alzheimer’s Association International Conference^® 2017
MENLO PARK, Calif. , July 18, 2017 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced that Parminder “Bobby” Singh , Ph.D., Corium’s…

Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-Weekly Corplex^TM Donepezil Transdermal System at Alzheimer’s Association International Conference^® 2017
MENLO PARK, Calif. , July 06, 2017 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Parminder “Bobby” Singh , Ph.D.,…